FluidForm

Our proprietary technology, published in Science, is the first in the world to build replacement tissues and organs. We are transforming medicine by building human tissue for drug discovery, surgical repair, and organ transplant. We were founded in 2018 on the belief that the world needs breakthrough technologies led by creative and passionate experts that help people lead better lives. Our mission is to integrate our breakthrough innovations in 3D printing, computational and synthetic biology, AI and Machine learning, and advanced materials science to develop human tissue that is indistinguishable from the real thing. Pursuing that goal is a leadership team with a unique combination of experiences from the fields of Life Sciences and Technology, and a broader team with deep domain expertise in hardware, software, biomedical engineering, machine learning, materials science, and medicine.